p53 peptide vaccine

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Breast CancerOvarian CancerOvarian Neoplasm

Phase 1

Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer

CompletedNCT00019916

National Cancer Institute (NCI)Breast Cancer, Ovarian Cancer

Start: 2000-06-30End: 2006-07-31Updated: 2013-06-20

Phase 2

p53 Vaccine for Ovarian Cancer

TerminatedNCT00001827

National Cancer Institute (NCI)Ovarian Neoplasm

Start: 1999-07-26End: 2013-01-25Updated: 2017-10-06